Ascendis Pharma A/S (ASND)
237.41
-3.09
(-1.28%)
USD |
NASDAQ |
May 18, 16:00
237.41
0.00 (0.00%)
After-Hours: 20:00
Ascendis Pharma Shareholders Equity (Quarterly) : 562.24M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Evaxion AS | 13.21M |
| Biodexa Pharmaceuticals Plc | -- |
| Rhythm Pharmaceuticals, Inc. | 122.91M |
| IO Biotech, Inc. | 0.911M |
| Amarin Corp. Plc | 449.41M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.308B |
| Total Liabilities (Quarterly) | 1.746B |
| Debt to Equity Ratio | 1.838 |
| Current Ratio | 0.9961 |
| Net Debt Paydown Yield | -0.21% |